Clinical trial
Effects of Exendin(9-39) on Gastroduodenal Motility
NCT00468091 · Ludwig-Maximilians - University of Munich, Other · Completed
Key facts
| NCT number | NCT00468091 |
|---|---|
| Title | Effects of Exendin(9-39) on Gastroduodenal Motility |
| Official title | Regulation of Antro-pyloro-duodenal and Proximal Gastric Motility by GLP-1: Involvement of Cholinergic Pathways |
| Lead sponsor | Ludwig-Maximilians - University of Munich, Other |
| Collaborators | German Research Foundation Philipps University Marburg |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Digestive Physiology, Gastrointestinal Motility, Gastrointestinal Hormones, Glucagon-like Peptide 1, Exendin (9-39) |
| Intervention type | Drug |
| Interventions | exendin(9-39)amide, atropine |
| Enrollment | 10 |
| Start date | Feb 1, 1999 |
| Completion | Sep 1, 2000 |
| First posted | May 1, 2007 |
| Last update posted | Apr 1, 2015 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: